四环医药分公司成立再生医用材料开发合资公司股价上涨3%

09:02 PM EST, 01/20/2022 (MT Newswires) -- Sihuan Pharmaceutical Holdings Group (HKG:0460) unit Beijing MeiYan KongJian Technology is establishing a joint venture with biomolecule developer Bluepha to develop and commercialize regenerative medical materials and PHA microspheres, according to a Friday filing.

PHA is microorganism-synthesized intracellular polyester that can be used for light medical aesthetics, the disclosure said.

Sihuan expects the deal to help it upgrade its medical aesthetics product matrix and non-surgical medical aesthetics capabilities.

Shares of the drugmaker rose over 3% in morning trade Friday.

Price (HKD): $1.66, Change: $+0.05, Percent Change: +3.11%